Titlebook: Liver Transplantation; Challenging Controve James F. Trotter,Gregory T. Everson Book 2009 Humana Press 2009 Surgery.Transplant Hepatology.c

淡紫色花

Liver Transplantation for Nonalcoholic Fatty Liver Disease,essive fibrosis and liver failure. NAFLD affects up to 30 million people in the United States with more than 600,000 with cirrhosis. With the increasing prevalence of obesity and type 2 diabetes in North America, NAFLD has become an important emerging public health issue. As the prevalence and sever

STELL

2197-7399 s who confront these issues on a daily basisLiver Transplantation: Challenging Controversies and Topics grew out of a need I perceived within the fields of transplant hepatology and liver transplantation. Liver transplantation has rightly gained recognition as an established therapy for end-stage li

floaters

precede

gerrymander

Liver Transplantation for Nonalcoholic Fatty Liver Disease,n the United States over the next decade. This review describes the prevalence, clinical characteristics, and pathogenesis of NAFLD. In addition, the management of NAFLD before and after liver transplantation is discussed.

STYX

indemnify

The Dilemma of Adult-to-Adult Living Donor Liver Transplantation,ve a potential living donor. The application of aLDLT in different regions of the world is discussed. In addition, the special issues related to aLDLT in patients with hepatocellular carcinoma and those infected with hepatitis C are reviewed.

重叠

llibretto

Tolerance in Liver Transplantation,oma or renal dysfunction. Because hepatitis C is the most common indication for liver transplantation, the application of immunosuppression in these patients is important. However, the best regimen for these patients remains controversial. The role of new immunosuppressive drugs including FTY720, FK

GLIDE

Novel Approaches to Immunosuppression in Liver Transplantation,noma or renal dysfunction. Because hepatitis C is the most common indication for liver transplantation, the application of immunosuppression in these patients is important. However, the best regimen for these patients remains controversial. The role of new immunosuppressive drugs including FTY720, F